CLINICAL_TRIALS
trial_result
· 2020-06-26
Clinical Trial Update: An Open Label Study of Oral Enzastaurin in Participants With Cancer [Phase 2]
Summary
Phase 2 open-label trial of oral enzastaurin in participants with cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-06-26